Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2023-03-24

Original market date: See footnote 1

1997-12-05

Product name:

ALLERGENIC EXTRACT - POLLENS

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02226928

Product Monograph/Veterinary Labelling:

Date: 2022-12-05 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

JUBILANT HOLLISTERSTIER LLC
3525 North Regal Street
Spokane
Washington
United States 99207

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Percutaneous ,  Subcutaneous ,  Intradermal

Number of active ingredient(s):

1

Schedule(s):

Schedule D

 

American Hospital Formulary Service (AHFS): See footnote 3

92:05.00* See footnote6 

Anatomical Therapeutic Chemical (ATC): See footnote 4

V01AA20 VARIOUS

Active ingredient group (AIG) number:See footnote5

0107826007

List of active ingredient(s)
Active ingredient(s) Strength
POLLEN 40000 UNIT / ML
Version 4.0.2
Date modified: